sur Medacta Group SA (isin : CH0468525222)
Medacta Group Acquires Parcus Medical for Sportsmedicine Expansion
Medacta Group SA has announced the acquisition of Parcus Medical, a specialist in sports medicine and arthroscopy solutions. This acquisition aims to boost Medacta's expansion in the sports medicine sector. Parcus Medical had a revenue of approximately USD 16 million in 2024 and offers a diverse range of products for surgical procedures on various joints.
With this acquisition, Medacta enhances its product portfolio and gains access to extensive global sales networks, including distributors in over 45 countries. This move also supports Medacta's presence in the US Ambulatory Surgery Centre market. The integration of Parcus Medical will bolster Medacta's strategy for sustainable growth in Sportsmed.
The acquisition was completed using existing resources, emphasizing Medacta's commitment to improving patient outcomes and healthcare sustainability.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Medacta Group SA